A recent meta-analysis reported a reduction in mortality and ventilation time with the use of IgM and IgA enriched immunoglobulin G in patients with sepsis or septic shock compared with the respective control groups (relative risk (RR) 0.60) [25]. This evidence concerns the gene CD79A and Sepsis.